Navigation Links
Biotech adds Central American markets to Sucanon distribution
Date:10/25/2007

VANCOUVER, Oct. 25 /PRNewswire-FirstCall/ - Biotech Holdings (the "Company", OTC BB: BIOHF.OB) reports that it has signed an agreement, with a private company based in El Salvador for marketing and distribution of its Sucanon Type II diabetes drug in four Central American countries, Guatemala, Honduras, Nicaragua and El Salvador.

The four new markets targeted in connection with this agreement have a total population of approximately 33 million people, with an estimated 775,000 cases of Type II Diabetes in the region.

The Central American markets will be served by Sucanon deliveries from the Company's contract-packager, based in Mexico City. The distributor will co-ordinate its advertising in the Central American region with advertising arranged by Biotech's office in Mexico.

This release has been approved by the Board of Directors of Biotech Holdings.

Robert B. Rieveley, Pres.

On behalf of the Board of Directors

Phone: 604 295 1119

Any statements made in this release that are not based on historical fact are forward-looking statements. Any forward-looking statements made in this release represent management's best judgement as to what may occur in the future. However, actual outcome and results are not guaranteed and are subject to certain risks, uncertainties and assumptions and may differ materially from what is expressed. There is no assurance that regulatory approval will be obtained in any specific market nor any assurance that sales, once begun, will be material.

CONTACT: Austin Rand at Biotech Holdings, 1-888-216-1111, or info@biotechltd.com; For background information on Biotech Holdings, or to receive news updates, see http://www.biotechltd.com


'/>"/>
SOURCE Biotech Holdings Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Finland and India to interact and cooperate in the filed of telemedicine and biotechnology
9. Vical Biotech and NIH jointly develops HIV vaccine
10. Biotechnology Initiatives Planned In Hyderabad
11. Biotech Osiris to go public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... , ... January 16, 2017 , ... ... today announced the addition of Victor Giamos, MD to their medical staff, according ... Managing Partner at North Shore Eye Care, a division of SightMD. Dr. Giamos ...
(Date:1/16/2017)... ... January 16, 2017 , ... Atlanta-based incentive company ... innovator in the wheelchair accessibility industry, BraunAbility . Incentive Solutions will provide ... wheelchair accessible vehicles. With this new incentive plan, BraunAbility plans to continue their ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... Aesthetic Surgery Journal , the official journal of The American Society for Aesthetic ... retraction surgery. The procedure is designed to correct drooping, retracted lower eyelids, which ...
(Date:1/16/2017)... ... January 16, 2017 , ... San Francisco dentist, Dr. Ben Amini , ... scanning device which is capable of taking digital impressions of teeth and gums. Conventional ... CAD CAM restorations , in terms of speed, efficiency and patient comfort. Increasingly, ...
(Date:1/15/2017)... York, NY (PRWEB) , ... January 15, 2017 , ... ... strategic accounts in the United States for the asthma & allergy friendly mark. This ... America to independently test and identify consumer products to be more suitable for the ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... Oregon and PUNE, India ... to a new report published by Allied Market Research, ... Global Opportunity Analysis and Industry Forecast, 2014-2022," the global ... by 2022, from $5,768 million in 2015, growing at ... chemical & gas sterilization segment dominated the market in ...
(Date:1/16/2017)... 16, 2017 Transparency Market Research states ... Devices Market  held a huge share of 43% in 2015. ... frontrunners in the overall market, grabbing the undivided attention of ... across geographies, and strong product portfolio is expected to keep ... ...
(Date:1/16/2017)... 16, 2017  Dovetail Genomics today announced the commercial ... service, which yields chromosome-scale genome assemblies. The service is ... workshop on Jan. 17 at the Plant & Animal ... . "We are thrilled to be ... our Dovetail Hi-C offering," said Todd Dickinson , ...
Breaking Medicine Technology: